 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
#subject-56492  1514 FM 359 About Labwire, Inc. Labwire Inc.was incorporated on October 8, 2004 as a Nevada corporation and is headquartered in Houston, Texas. It provides secure and compliant customized full service drug and alcohol testing and other employment screening including billing, customized reports, collection site identification and management, Medical Review Officer (MRO) services, education, client support systems, background checks, physicals, K-9 surveillance and more to Fortune 500 corporations via the Labwire™ Platform. Labwire™ is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry. Not just another database, Labwire™ was developed by our team of industry leaders to deliver comprehensive and secure employer information management services over the Internet. Labwire’s Network Administrator previously worked alongside with the federal government in writing the HIPPA law. At the same time we provide the most comprehensive time-saving workflow automation system on the market. The Labwire operating platform, which provides modular delivery systems, procedures compliant with HIPAA protocols (unique within the industry), and live user-friendly access to all clients, all while adhering to ISO 9000:2000 certification standards (also unique within the industry). For more information see 8-k filings. Officers and Directors and Key Employees CEO G. Dexter Morris - Message 24648964 The Labwire management team is made up of experienced personnel along with two senior client service directors. The core management team managed the sale of over $110 million in drug testing, backgrounds, and related services before forming Labwire, Inc. and taking advantage of their experience and expertise, including their in depth knowledge of the required Department of Transportation (“DOT”) testing regulations (49 CFR, Part 40). As a result of these efforts, Labwire: (1) enables clients to effectively manage drug testing programs over the Internet; (2) provides clients with secure and centralized, collection and analysis of highly confidential data produced by drug testing; and (3) allows for Web-enabled access to individual test results and other detailed compliance reports. These revenues account for approximately 60% of Labwire’s revenues. Through the implementation of Labwire’s technology, the Company anticipates evolving from a traditional TPA service provider to a leading substance abuse program application service provider (“ASP”). Services Message 24684032 Principal Suppliers and Partners Message 24703144 Strategic Acquisitions Occupational Testing, Inc. - Message 24675881 Occupational Testing Website - occtesting.com Alliance Agreements Labwire Signs Alliance Agreement With USIS - Message 24680636 USIS Website - usis.com Labwire Signs Alliance with Global Medical Testing - Message 24768919  Current News ~~~~> finance.yahoo.com Description of Securities Common Stock On May 27, 2008, the Board of Directors and shareholders owning approximately 85% of the Company’s issued and outstanding common shares voted to increase its authorized shares of common stock from 150,000,000 to 200,000,000 at par value of $0.001 per share. Preferred Stock Our Articles of Incorporation do not authorize the issuance of Preferred Stock. There are presently no shares of preferred stock outstanding. The Company has not effectuated a change of control, or an increase in its authorized common stock. There are no past, pending or anticipated stock splits, stock dividends, recapitalizations, mergers, acquisitions, spin-off, or reorganizations. Transfer Agent The transfer agent and registrar for our Common Stock is Holliday Stock Transfer, Inc., 2939 N. 67th Place, Scottsdale, AZ, 85251. Phone (480) 481-3940 - Sharon. Share Structure per T.A. - November 25, 2008 Authorized Shares: 200,000,000 Also Visit Labwire iHub - investorshub.com **Attention** Please read - Message 24940195 | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |